Tell us about your biggest client wins this year. [The firm] represented Teva Pharmaceuticals in a fraud and contract breach suit arising from a $2.3 billion acquisition of a Mexican pharmaceutical company. The case settled on extremely favorable terms after only 17 months. [The firm represents] investors in the Alibaba securities fraud case relating to its $25 billion initial public offering. It emerged that pre-IPO Chinese regulators threatened billions of dollars of fines based on the prevalence of counterfeits. The stock dropped significantly. The suit was dismissed. [The firm was] retained and the Second Circuit reversed. Following expert depositions, it settled for $250 million.

What’s the best lesson you learned as a young lawyer? Don’t underestimate, but don’t overestimate your opponent. In essence, be practical. Assess the case and pursue it with a solid dose of reality.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]